About
Sean Ainsworth is a biotech executive and entrepreneur who serves as CEO and Chairman of Immusoft. He previously founded and led RetroSense Therapeutics, which advanced into human clinical trials and was sold to Allergan in 2016 in a deal valued at up to $555 million. He also serves as Lead Independent Director at Opus Genetics and co-founded Ray Therapeutics, where he is Chairman.
Areas of interest
biotechgene therapycell therapyrare diseaseophthalmologygenetic medicinedrug developmentlife sciences commercialization